Stockhead
 
Biocurious: Aroa brings a touch of ‘magic’ to the US$3 billion woundcare sector

Biocurious: Aroa brings a touch of ‘magic’ to the US$3 billion woundcare sector

On the back of stellar financial results, Aroa Biosurgery reckons it has only just begun to penetrate the capacious US market.

 
Rise and Shine: Everything you need to know before the ASX opens

Rise and Shine: Everything you need to know before the ASX opens

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

 
 
The Odyssey: Gold junior eyes re-rate opportunity with 2027 production in sight

The Odyssey: Gold junior eyes re-rate opportunity with 2027 production in sight

Odyssey Gold is charting a course to gold production – and a re-rate – after signing a processing deal for its Tuckanarra mine in WA.

 
Beyond FDA approval: How ASX medical device plays are cracking US market

Beyond FDA approval: How ASX medical device plays are cracking US market

Securing US FDA approval is a milestone for medical device companies but is only half the story with successful adoption also challenging.

 
Copper crunch puts juniors in the deal room

Copper crunch puts juniors in the deal room

A tightening copper market is opening a rare window for ASX juniors with near-term tonnes, high-grade sulphides and fast-moving projects.

 
The war behind the war – why connectivity is becoming the new battlefield